High-precision orthopedic traumatology implants and specialized surgical devices engineered to maximize procedural efficiency and patient healing kinetics.
Analyzing the macroeconomic shifts, regulatory pressures, and supply chain demands driving modern orthopedic traumatology procurement.
Global medical device brands are shifting from in-house production to highly specialized OEM/ODM partnerships. This paradigm minimizes capital expenditure (CapEx), accelerates time-to-market, and shifts manufacturing risks to certified suppliers like Synoviq. Leveraging high-efficiency machining allows global partners to optimize their resource allocation towards clinical trials, regulatory filings, and global distribution.
Biomedical engineering demands absolute compliance with standards such as ASTM F136 (Titanium-6Aluminum-4Vanadium ELI) and ISO 5832. Modern trauma implants require optimized biomechanical features, including high fatigue resistance, low Young’s modulus to reduce stress shielding, and state-of-the-art surface treatments to enhance bone-implant interface kinetics (osseointegration).
The regulatory transition from the MDD to the European Union Medical Device Regulation (EU MDR 2017/745), along with the stringent FDA 510(k) premarket notifications, requires factories to maintain a highly detailed and audit-ready Quality Management System (QMS). Synoviq maintains a comprehensive Class III medical device footprint, ensuring seamless traceability and mechanical validation datasets.
A Class III medical device pioneer, establishing global standards in high-performance orthopedic traumatology fabrication, surgical instrumentation, and clinical ODM solutions.
Synoviq Medical Technology (China) Co., Ltd. is a professional manufacturer of orthopedic implants and surgical instruments, dedicated to delivering innovative, reliable, and high-quality medical solutions for healthcare professionals worldwide. Since its establishment, Synoviq has focused on research, development, precision manufacturing, and international quality standards, providing comprehensive OEM and ODM services for global medical device brands, distributors, and hospitals.
Our product portfolio includes trauma fixation systems, spinal implants, locking plates, intramedullary nails, external fixation systems, orthopedic screws, surgical instruments, and customized orthopedic solutions. Equipped with advanced CNC machining centers, precision inspection equipment, and modern clean production facilities, we ensure every product meets strict international quality requirements.
Driven by continuous innovation, Synoviq invests heavily in R&D and intelligent manufacturing to enhance product performance, surgical efficiency, and patient outcomes. Our experienced engineering team works closely with customers to develop customized products tailored to different clinical applications and market demands.
With a customer-oriented philosophy, competitive pricing, stable supply capability, and efficient technical support, Synoviq has established long-term partnerships with distributors, medical brands, and healthcare organizations across Europe, North America, South America, the Middle East, and Asia-Pacific.
| Specification Parameter | Enterprise Capability Dataset |
|---|---|
| Company Name | Synoviq Medical Technology (China) Co., Ltd. |
| Brand | Synoviq |
| Established | March 18, 2016 |
| Building Area | 18,600 m² |
| Annual Export Revenue | USD 21.8 Million |
| Export Experience | 8 Years |
| Industry Experience | 14 Years |
| Quality Inspection | 100% Final Inspection & Incoming Material Inspection |
| Product Inspection Methods | CMM Measurement, Mechanical Testing, Surface Roughness Testing, Hardness Testing, Salt Spray Testing, Sterility Validation |
| Quality Control Staff | 48 Specialists |
| Business Type | Manufacturer & Exporter (OEM/ODM) |
| Main Markets | Europe, North America, South America, Middle East, Southeast Asia |
| Supply Chain Partners | 1,120+ Verified Entities |
| Main Customer Types | Medical Device Brands, Importers, Distributors, Hospitals, Government Procurement Projects |
| R&D Capability | Independent Product Design, Prototype Development, Clinical-Oriented Engineering, OEM & ODM Development |
| Customization Options | Logo Customization, Packaging Customization, Product Design Customization, Material Selection, Surface Treatment |
| New Products Released Last Year | 186 Innovative SKUs |
| R&D Engineers | 76 Full-Time Structural & Biomaterials Engineers |
Ensuring absolute structural integrity through an integrated fabrication line, from raw billet cutting to final clinical-grade sterilization packaging.
Zero-defect execution utilizing ISO 13485 calibration standards, high-magnification digital micro-imaging, and dynamic mechanical fatigue analysis.
How Synoviq addresses regional raw material shortages, price volatility, and stringent regulatory barriers through robust production logistics.
To eliminate material defects and ensure biological compatibility, Synoviq works exclusively with Tier-1 medical-grade titanium and cobalt-chromium suppliers. Every raw batch is subjected to internal spectrometer validation and metallographic structure analysis. By maintaining a 6-month buffer of raw medical-grade metals, we shield our global OEM clients from price shocks and shipping delays in the upstream refining sectors.
For orthopedic implants, packaging verification is as critical as mechanical strength. Synoviq operates Class 10,000 (ISO Class 7) and Class 100,000 (ISO Class 8) cleanrooms for product cleaning, sorting, assembly, and primary sealing. Package integrity testing is conducted using specialized leakage and seal testers, ensuring products reach hospitals completely aseptic, ready for Gamma or EtO sterilization protocols.
Predicting the future of trauma treatment through additive manufacturing, smart surfaces, and customizable locking geometries.
By mimicking trabecular bone porosity, selective laser melting (SLM) titanium structures encourage direct bone in-growth. Synoviq is integrating advanced additive manufacturing pathways to transition from standard subtractive CNC machining to hybrid manufacturing, allowing customizable orthopedic solutions for complex trauma reconstructions.
Nosocomial infections are major challenges in orthopedic surgeries. Our technology roadmap features silver/copper ion-doped anodic coatings. These coatings provide targeted bactericidal effects at the surgical site without compromising local osteogenesis or triggering systemic cytotoxicity, establishing a new standard in post-operative recovery safety.
For temporary fixation devices like interference screws and pins, secondary surgeries for implant removal are undesirable. Synoviq is researching controlled-degradation magnesium alloys that gradually transfer mechanical load to the healing bone structure, dissolving safely after osteotomy fusion is achieved.
Ensuring seamless custom clearance, local agent registration, and clinical trial compilation in regional jurisdictions.
Navigating global regulatory pathways requires deep domain expertise. Synoviq does not merely supply medical implants; we partner with global distributors to facilitate direct regional regulatory approvals. Our regulatory department generates all necessary documentation, including Design History Files (DHF), Device Master Records (DMR), clinical evaluation reports (CER), biocompatibility datasets (ISO 10993), and mechanical validation reports (fatigue, shear, pull-out resistance).
With our established presence in Europe, North America, South America, the Middle East, and Southeast Asia, we maintain a clear understanding of the specific requirements of the FDA, MHRA, ANVISA, and SFDA. This ensures a frictionless flow of class III products across international borders, protecting your institutional brand reputation and commercial investments.
Expert responses regarding raw materials, mechanical tolerances, certification details, and OEM integration parameters.
Explore our secondary catalog of spine, joint, and trauma reconstruction components designed for demanding clinical applications.
Synoviq Medical